HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Council Proposes "Modernized" FDA Oversight Of Personal-Care Industry

This article was originally published in The Rose Sheet

Executive Summary

The largely self-regulated personal-care industry has announced its support of legislation to expand FDA's oversight role

You may also be interested in...



Cosmetics Legislative Plans Vie In Congress

Rep. Frank Pallone, D-N.J., introduces the Cosmetic Safety Enhancement Act of 2012 before March 27th’s Energy and Commerce hearing on cosmetics regulation. Representatives Jan Schakowsky and Ed Markey push for their Safe Cosmetics Act of 2011, while Rep. Leonard Lance, R-N.J., intends to introduce his own cosmetics plan.

House Hearing Probes FDA’s Cosmetics Role

Stakeholders from industry, government and FDA discussed ideas for changing the agency’s oversight of cosmetics at a House subcommittee meeting March 27. The need for a national regulatory system, mandatory recalls, company and ingredient registration and adverse event reporting were debated.

FDA, Industry To Testify At House Cosmetics Hearing

A March 27 hearing titled “Examining the Current State of Cosmetics” will likely focus more on the future of cosmetics regulation in the U.S. CFSAN director Michael Landa is slated to testify, as are representatives from the Personal Care Products Council and small businesses.

Related Content

UsernamePublicRestriction

Register

RS017065

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel